InvestorsHub Logo
Followers 0
Posts 4557
Boards Moderated 0
Alias Born 09/05/2005

Re: BonelessCat post# 33486

Wednesday, 06/02/2010 2:23:51 PM

Wednesday, June 02, 2010 2:23:51 PM

Post# of 146240
I don't think its fair to accuse me of misinformation.
What about this post of yours from 2008


Posted by: DrFeelgood Date: Thursday, January 03, 2008 12:54:17 AM
In reply to: Livingstone821 who wrote msg# 8388 Post # of 33419<<<

In which he stated that...

So, timelines:

1) Animal studies to be completed by end of March: Ebola, Marburg, Dengue, H5N1, Rabies and Viral Keratoconjunctivitis.
Confirmation of all previous studies with fine tuning of the targeting ligands for the nanoviricide to increase efficacy. Testing of RabiCide showing nearly 100% survival prodrome (after the earliest onset of symptoms). EbolaCide and DengueCide should be reported by end of January, though the company is at the mercy of government researchers who must first report findings before NNVC can report.

2) Expecting a lease or purchase of 100K sq. ft cGMP facility by end of February. I would suspect that the facility will be in a state where development grants and funds are available. That actually limits the possibilities. (See #3) The facility would still need to be retrofitted for production of nanoviricides. Also, staff will still need to be hired and trained.

3) Government development funding release. Announcement of a state development funding. I know it won't be Hawaii and Alaska is too cold, so that narrows it down to only 48 possibilities. Texas, Utah and Pennsylvania have all come up as having business development grants. Nevada is both the state of incorporation and looking to develop a revenue base aside from gambling, but who the heck wants to live there. New Mexico has money, but is lacking in research universities. Florida is like California as it needs no growth and will be under water in 50 years. Wisconsin and Michigan are in similar positions as New Mexico, though the School of Public Health at Ann Arbor is in expansion of its BSL-3 research center. If it were to be Massachusetts, Connecticut or New York it would already be a done deal. Oregon doesn't want to be Californicated and Washington doesn't want to fund. Much of the South is just too angry at nano-science and "researchers playing God with gene manipulation. The Idaho, Nebraska, the Dakotas and Montana are all AG centers. All in all, that kinda leaves Texas, Utah, Pennsylvania and the one site in Michigan.

4) H5N1 primate study completed by March.

5) Licensing of at least one early development drug (probably EbolaCide-HP or DengueCide-HP, though it could also be Viral Keratoconjunctivitis-Cide-HP) to a big pharma.

OK, that's a good start for the year. And, by the way, all just MHO.

I think all those predictions were based on what was read into company PRs and communications, but in reality none of these took place.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News